Report of the Relapsed/Refractory Cohort of SWOG S0919: A Phase 2 Study of Idarubicin and Cytarabine in Combination with Pravastatin for Acute Myelogenous Leukemia (AML)
Source: Leukemia Research - Category: Hematology Authors: Anjali S. Advani, Hongli Li, Laura C. Michaelis, Bruno C. Medeiros, Michaela Liedtke, Alan F. List, Kristen O ’Dwyer, Megan Othus, Harry P. Erba, Frederick R. Appelbaum Tags: Research paper Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Leukemia | Pravastatin | Statin Therapy | Study